Patent Issued for Drug and production method therefor (USPTO 11951125).

Osaka University has been issued a patent for a drug and its production method that aims to address kidney disease. The patent describes a drug that includes silicon fine particles and hydrogen-generating materials, which generate hydrogen when in contact with a water-containing liquid in the intestine. The drug is intended for oral ingestion and is designed to reduce or eliminate oxidative stress on the kidneys by reacting with hydroxyl radicals. The invention seeks to simplify the production process, lower costs, and improve the effectiveness and safety of treatments for kidney disease. [Extracted from the article]